title: Imatinib mesylate-induced neutrophilic folliculitis in a teenager.
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: García-Romero
authors.forename: Carola
authors.initials: C
authors.lastname: Durán-McKinster
authors.forename: Marimar Sáez
authors.initials: MS
authors.lastname: de Ocariz
authors.forename: Daniel
authors.initials: D
authors.lastname: Carrasco-Daza
authors.forename: Carolina
authors.initials: C
authors.lastname: Palacios-López
authors.forename: Luz
authors.initials: L
authors.lastname: Orozco-Covarrubias
authors.forename: Ramón
authors.initials: R
authors.lastname: Ruiz-Maldonado
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects; D001549:Benzamides / Q000009:adverse effects*; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000276:immunology; D005260:Female; D005499:Folliculitis / Q000139:chemically induced* / Q000276:immunology; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects* / Q000276:immunology; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate